Top compounds associated with response to EIF2S3L


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.2
mRNA Curcumin CTRPv2 pan-cancer AAC -0.04 0.2
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.042 0.2
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.057 0.2
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC -0.061 0.2
mRNA SR-II-138A CTRPv2 pan-cancer AAC -0.036 0.2
mRNA ML006 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC -0.061 0.2
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.041 0.2
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC -0.043 0.3
Download CSV